Clinical trial
Phase 2 Study of IL-1 Trap (Rilonacept) for Treatment of Familial Mediterranean Fever (FMF)
NCT00582907 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 2 Study of IL-1 Trap (Rilonacept) for Treatment of Familial Mediterranean Fever (FMF)
- Lead sponsor
- The Cleveland Clinic
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 31, 2008
- Completion date
- September 30, 2011
- Enrollment
- 14 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.